EDGAR Filing Documents for 0001096906-17-000107

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

SEC Accession No. 0001096906-17-000107

Filing Date

2017-02-17

Accepted

2017-02-17 12:32:39

Documents

Period of Report

2016-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q AMENDMENT NO. 1	aoxing.htm	10-Q/A	559409
2	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2	exh31_1.htm	EX-31.1	8388
3	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2	exh31_2.htm	EX-31.2	8739
4	CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350.	exh32_1.htm	EX-32.1	4950
5	CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350.	exh32_2.htm	EX-32.2	4991
	Complete submission text file	0001096906-17-000107.txt		2817128

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	axn-20161231.xml	EX-101.INS	539021
7	XBRL TAXONOMY EXTENSION SCHEMA	axn-20161231.xsd	EX-101.SCH	35019
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	axn-20161231_cal.xml	EX-101.CAL	33228
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	axn-20161231_def.xml	EX-101.DEF	53816
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	axn-20161231_lab.xml	EX-101.LAB	170635
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	axn-20161231_pre.xml	EX-101.PRE	153021

Mailing Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404

Business Address 1098 FOSTER CITY BLVD. SUITE 106-810 FOSTER CITY CA 94404 646-367-1747

AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)